Sei Investments Co. Has $4.97 Million Stock Position in HealthStream, Inc. (NASDAQ:HSTM) (2025)

Sei Investments Co. boosted its stake in shares of HealthStream, Inc. (NASDAQ:HSTM – Free Report) by 3.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 178,019 shares of the technology company’s stock after buying an additional 6,592 shares during the period. Sei Investments Co. owned about 0.59% of HealthStream worth $4,967,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Harbor Capital Advisors Inc. raised its holdings in shares of HealthStream by 197.8% during the second quarter. Harbor Capital Advisors Inc. now owns 165,885 shares of the technology company’s stock valued at $4,628,000 after acquiring an additional 110,189 shares during the period. First Eagle Investment Management LLC boosted its position in HealthStream by 21.5% during the 1st quarter. First Eagle Investment Management LLC now owns 494,828 shares of the technology company’s stock worth $13,192,000 after acquiring an additional 87,400 shares during the period. Assenagon Asset Management S.A. grew its stake in HealthStream by 58.6% during the 2nd quarter. Assenagon Asset Management S.A. now owns 146,826 shares of the technology company’s stock valued at $4,096,000 after acquiring an additional 54,227 shares in the last quarter. Wakefield Asset Management LLLP acquired a new position in shares of HealthStream in the 1st quarter valued at about $909,000. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of HealthStream by 97.1% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 67,296 shares of the technology company’s stock valued at $1,878,000 after purchasing an additional 33,161 shares during the period. 69.58% of the stock is owned by hedge funds and other institutional investors.

HealthStream Stock Up 1.4 %

Shares of HSTM stock opened at $29.25 on Wednesday. The business’s 50 day moving average is $28.61 and its two-hundred day moving average is $27.56. HealthStream, Inc. has a 12 month low of $21.49 and a 12 month high of $31.15. The company has a market cap of $889.14 million, a PE ratio of 50.93, a price-to-earnings-growth ratio of 4.25 and a beta of 0.36.

HealthStream (NASDAQ:HSTM – Get Free Report) last announced its earnings results on Monday, July 22nd. The technology company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The firm had revenue of $71.56 million for the quarter, compared to the consensus estimate of $72.85 million. During the same quarter last year, the firm posted $0.13 EPS. The business’s quarterly revenue was up 3.4% on a year-over-year basis. As a group, equities analysts expect that HealthStream, Inc. will post 0.56 EPS for the current fiscal year.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Stockholders of record on Monday, August 5th were given a dividend of $0.028 per share. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date was Monday, August 5th. HealthStream’s dividend payout ratio is currently 18.97%.

Analyst Ratings Changes

A number of research analysts recently commented on HSTM shares. Canaccord Genuity Group boosted their price objective on shares of HealthStream from $27.00 to $28.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. StockNews.com downgraded shares of HealthStream from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $30.00.

Check Out Our Latest Research Report on HealthStream

Insider Buying and Selling

In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the transaction, the director now owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, Director Tate Deborah Taylor sold 1,400 shares of HealthStream stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the sale, the director now directly owns 22,326 shares in the company, valued at approximately $636,960.78. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Kevin P. O’hara sold 3,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $28.03, for a total transaction of $84,090.00. Following the completion of the sale, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. The disclosure for this sale can be found here. 20.60% of the stock is owned by company insiders.

About HealthStream

(Free Report)

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.

Featured Stories

• Five stocks we like better than HealthStream
• Why Special Dividends Can be a Delightful Surprise for Income Investors
• Why Lennar Stock Could Be the Best Play in the Housing Market
• Upcoming IPO Stock Lockup Period, Explained
• 2 Energy Stocks Fueling the AI Datacenter Boom
• What is a Low P/E Ratio and What Does it Tell Investors?
• Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.